Pyxis Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pyxis Oncology and other ETFs, options, and stocks.About PYXS
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
CEOLara S. Sullivan
CEOLara S. Sullivan
Employees44
Employees44
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2018
Founded2018
Employees44
Employees44
PYXS Key Statistics
Market cap116.43M
Market cap116.43M
Price-Earnings ratio-1.18
Price-Earnings ratio-1.18
Dividend yield—
Dividend yield—
Average volume2.13M
Average volume2.13M
High today$1.99
High today$1.99
Low today$1.97
Low today$1.97
Open price$2.06
Open price$2.06
Volume2.12K
Volume2.12K
52 Week high$5.55
52 Week high$5.55
52 Week low$0.8332
52 Week low$0.8332
Stock Snapshot
The current Pyxis Oncology(PYXS) stock price is $1.97, with a market capitalization of 116.43M. The stock trades at a price-to-earnings (P/E) ratio of -1.18.
On 2026-01-14, Pyxis Oncology(PYXS) stock moved within a range of $1.97 to $1.99. With shares now at $1.97, the stock is trading 0.0% above its intraday low and -1.0% below the session's peak.
Trading volume for Pyxis Oncology(PYXS) stock has reached 2.12K, versus its average volume of 2.13M.
The stock's 52-week range extends from a low of $0.83 to a high of $5.55.
The stock's 52-week range extends from a low of $0.83 to a high of $5.55.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own PYXS. This list is generated using Robinhood data, and it’s not a recommendation.